X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-18
ACTAVIS
Dec-14
ALEMBIC PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs64519,644-   
Low Rs47011,982-   
Sales per share (Unadj.) Rs166.13,537.4-  
Earnings per share (Unadj.) Rs21.9-441.4-  
Cash flow per share (Unadj.) Rs27.5324.5-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs117.87,672.5-  
Shares outstanding (eoy) m188.52265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.5 75.1%   
Avg P/E ratio x25.5-35.8 -71.1%  
P/CF ratio (eoy) x20.348.7 41.6%  
Price / Book Value ratio x4.72.1 229.7%  
Dividend payout %18.30-   
Avg Mkt Cap Rs m105,0904,204,782 2.5%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m6,2280-   
Avg. sales/employee Rs ThNM43,546.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,434.1-  
INCOME DATA
Net Sales Rs m31,308940,595 3.3%  
Other income Rs m70-2,348 -3.0%   
Total revenues Rs m31,378938,247 3.3%   
Gross profit Rs m6,431120,833 5.3%  
Depreciation Rs m1,055203,673 0.5%   
Interest Rs m3429,668 0.1%   
Profit before tax Rs m5,413-114,856 -4.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-810-   
Extraordinary Inc (Exp) Rs m0-8,425 0.0%   
Tax Rs m1,204-5,905 -20.4%   
Profit after tax Rs m4,128-117,376 -3.5%  
Gross profit margin %20.512.8 159.9%  
Effective tax rate %22.25.1 432.5%   
Net profit margin %13.2-12.5 -105.7%  
BALANCE SHEET DATA
Current assets Rs m18,247495,573 3.7%   
Current liabilities Rs m11,235361,418 3.1%   
Net working cap to sales %22.414.3 157.0%  
Current ratio x1.61.4 118.4%  
Inventory Days Days8658 147.5%  
Debtors Days Days6166 92.6%  
Net fixed assets Rs m20,035114,856 17.4%   
Share capital Rs m3770-   
"Free" reserves Rs m21,8240-   
Net worth Rs m22,2012,040,115 1.1%   
Long term debt Rs m5,0001,069,060 0.5%   
Total assets Rs m39,4113,738,860 1.1%  
Interest coverage x160.2-2.9 -5,579.0%   
Debt to equity ratio x0.20.5 43.0%  
Sales to assets ratio x0.80.3 315.8%   
Return on assets %10.6-2.3 -450.2%  
Return on equity %18.6-5.8 -323.2%  
Return on capital %19.7-3.0 -655.2%  
Exports to sales %46.40-   
Imports to sales %10.50-   
Net fx Rs m7,6960-   
CASH FLOW
From Operations Rs m3,124161,518 1.9%  
From Investments Rs m-8,844-386,737 2.3%  
From Financial Activity Rs m5,026217,290 2.3%  
Net Cashflow Rs m-693-7,928 8.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.01 Rs / USD

Compare ALEMBIC PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: PFIZER  JUBILANT LIFE SCIENCES  MERCK LTD  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Sensex Trades 370 Points Up; Hero MotoCorp & Tata Motors Gain Over 5%(12:30 pm)

Stock markets in India are presently trading higher following the outcome of assembly polls announced on Tuesday.

Related Views On News

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Dec 12, 2018 03:35 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS